The research, conducted by a team at the Oklahoma Medical Research Foundation and collaborators, set out to test a hypothesis that human genetics has long hinted at but never cleanly confirmed. Mitochondria carry their own small circle of DNA, inherited almost exclusively through the maternal line, and specific combinations of variants in this DNA define haplogroups that vary across human populations. Large observational studies have suggested that women in certain haplogroups fare better: Caucasian women carrying the JT macro-haplogroup showed roughly a threefold lower risk of diminished ovarian reserve, and Taiwanese women in haplogroup R maintained oocyte yield and cellular aging markers independent of age. But human haplogroups travel with nuclear ancestry and environment, making it impossible to say whether the mitochondrial DNA itself is doing the work. The new study built an animal model in which that confounding is dismantled by design.

The investigators used a genetically heterogeneous rat line produced by a four-way cross of inbred strains: Brown Norway, Fischer 344, Lewis and Wistar Kyoto. By reciprocal breeding, they generated two cohorts that carry identical expected contributions from all four founder strains in their nuclear genomes, but differ in their maternally inherited mitochondrial DNA. One cohort, designated OKC-HET-B, carries Brown Norway mtDNA; the other, OKC-HET-W, carries Wistar Kyoto mtDNA, which differs by 94 nucleotides, a divergence comparable to that separating human haplogroups. Because nuclear variation is randomized with respect to mitochondrial haplotype rather than co-inherited with it, any consistent difference between the cohorts points squarely at the mitochondrial genome or its interaction with the nucleus.

Tracking ovaries at four, nine and fourteen months of age, the team found that the two haplotypes started from the same place but diverged sharply in the middle. At four months, follicle counts at every developmental stage were indistinguishable between cohorts. By nine months, however, both the primordial follicle pool and the total follicle count were significantly depleted in OKC-HET-W ovaries, indicating an accelerated exhaustion of the finite reserve of eggs. By fourteen months, when both cohorts had lost most follicles, the difference had vanished. The pattern is striking: mitochondrial haplotype did not determine how large the ovarian reserve was at establishment, nor when it ultimately ran out, but rather the speed at which it was spent in between.

The tissue itself told a parallel story. Collagen deposition, measured by Picrosirius Red staining, rose gradually with age in OKC-HET-B ovaries, but was already pronounced in OKC-HET-W ovaries at four months and stayed elevated thereafter. Fibrosis of the ovarian stroma is increasingly recognized as a barrier to ovulation, and antifibrotic drugs have been shown to restore fertility in reproductively old mice. Alongside the fibrosis came an earlier shift in immune composition: total leukocyte abundance, marked by CD45, was elevated in OKC-HET-W ovaries at four months, macrophage infiltration followed by nine months, and by nine and fourteen months the OKC-HET-W stroma was littered with lipofuscin-rich multinucleated giant cells, a macrophage-derived population considered a hallmark of the chronically inflamed aged ovary. In effect, the W haplotype ovaries were aging ahead of schedule, building an inflammatory, scarred microenvironment before significant follicle loss had even begun.

What could a handful of mitochondrial DNA variants possibly be doing to drive this? The team’s bioenergetic measurements pointed to early functional deficits. By four months, OKC-HET-W ovaries already showed significantly lower activity of NADH oxidase and respiratory chain complex I, along with reduced ATP content. Mitochondrial membrane potential, assessed by JC-1 staining of single-cell suspensions, declined with age in both cohorts but fell further and stayed lower in the W haplotype. Critically, these defects were not explained by having fewer mitochondria: mitochondrial mass, measured by MitoTracker staining, and the abundance of dynamics regulators such as FIS1 and MFN1 were comparable between haplotypes. Quality, not quantity, was the difference.

The molecular trail then led to the management of the mitochondrial genome itself. mtDNA copy number was consistently lower in OKC-HET-W ovaries at every age, and chromatin immunoprecipitation revealed that TFAM, the nuclear-encoded protein that packages and stabilizes mtDNA, bound significantly less to mitochondrial genes in young W-haplotype ovaries. Paradoxically, total TFAM protein was actually higher in these ovaries, but subcellular fractionation showed less TFAM inside the mitochondria, accompanied by reduced abundance of TOMM20, a key component of the outer-membrane protein import machinery. The picture that emerges is one of impaired mitochondrial protein import: TFAM is made but fails to reach its destination, leaving the mitochondrial genome poorly maintained. The authors also note that the two haplotypes differ within the D-loop regulatory region to which TFAM binds, so a sequence-level contribution to reduced binding cannot be ruled out, and the two mechanisms may well operate together. Notably, a parallel exists in human populations, where mtDNA copy number declines as mitochondrial and nuclear ancestry become more discordant, suggesting that mitonuclear coordination may matter for reproductive aging in people too.

Transcriptomic and proteomic profiling added a genome-wide dimension. Direct comparisons between haplotypes at single time points revealed relatively few differences early on, indicating that the initial phenotypic divergence is not driven by massive transcriptional rewiring. But when the team compared each cohort against its own younger self, a dramatic bifurcation appeared: between four and fourteen months, OKC-HET-W ovaries underwent far more extensive molecular change than OKC-HET-B ovaries, with strong activation of inflammatory and fibrotic signaling and coordinated suppression of protein synthesis, proteostasis, cell-cycle control, and, tellingly, mitochondrial protein import. Among respiratory chain subunits, the ones that differed between haplotypes were exclusively nuclear-encoded, while the few mtDNA-encoded subunits detected were unchanged, placing the mitochondrial genome upstream of altered nuclear gene output, exactly as a mitonuclear coordination defect would predict.

The functional consequences were measurable even in young animals. Following hormonal superovulation at four months, OKC-HET-W females released significantly fewer oocytes than their B-haplotype counterparts, and confocal imaging of meiotic spindles revealed a higher proportion of abnormal, disorganized or multipolar spindles with misaligned chromosomes, roughly double the rate seen in B-haplotype oocytes, though with the sample size this comparison narrowly missed statistical significance. Plasma anti-Müllerian hormone, a clinical marker of ovarian reserve and follicle maturation, was also significantly lower in the W haplotype. From mitochondrial enzyme activity to tissue architecture to the quality of the egg itself, the same haplotype disadvantage propagated across every biological scale examined.

The study is not without caveats, which the authors confront directly. The reciprocal cross design, while balancing autosomal ancestry, does not randomize the paternally inherited X chromosome, and X-linked contributions cannot be formally excluded; the definitive test will be conplastic strains carrying a single haplotype on a fixed nuclear background, a breeding project the team regard as the natural next step. Still, the design constrains the plausible architectures considerably, since a purely nuclear defect in the WKY strain would predict impairment in the opposite cohort. Taken together, the findings establish, for the first time in an experimentally controlled setting, that naturally occurring mitochondrial haplotype variation is a heritable modifier of the pace of ovarian aging. They reframe the mitochondrial genome not merely as the cell’s power supply but as an inherited timer that, in conversation with the nuclear genome, helps set the length of a woman’s reproductive lifespan, and they raise the tantalizing prospect that mitochondria-targeted interventions might one day be deployed to slow that clock.

Subject of Research: The role of mitochondrial DNA haplotype variation in determining the rate of ovarian aging and follicle depletion

Article Title: Mitochondrial Haplotype Shapes the Trajectory of Ovarian Aging in Genetically Heterogeneous Rats

Article References: Biswas, S., Nguyen, H. V. M., Converse, A., Matsuzaki, S., Kinter, M. T., Humphries, K. M., Freeman, W. M., Ocañas, S. R., Richardson, A., Duncan, F. E., Lewis, T. L., Jr, & Stout, M. B. (2026). Mitochondrial Haplotype Shapes the Trajectory of Ovarian Aging in Genetically Heterogeneous Rats. Aging Cell, 25(9), Article e70710. https://doi.org/10.1111/acel.70710

Image Credits: AI Generated

DOI: 10.1111/acel.70710

Keywords: ovarian aging, mitochondrial DNA, haplotype, follicle depletion, mitonuclear interaction, TFAM, ovarian reserve, fibrosis, inflammaging, oocyte quality, reproductive lifespan, rat model